Non-Langerhans cell histiocytosis
| Non-Langerhans cell histiocytosis | |
|---|---|
| Synonyms | Histiocytosis X, Erdheim–Chester disease, Juvenile xanthogranuloma |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Skin lesions, Bone pain, Diabetes insipidus, Exophthalmos |
| Complications | Organ failure, Neurological complications |
| Onset | Variable, can occur at any age |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly genetic mutations |
| Risks | Unknown |
| Diagnosis | Biopsy, Imaging studies, Blood tests |
| Differential diagnosis | Langerhans cell histiocytosis, Sarcoidosis, Lymphoma |
| Prevention | N/A |
| Treatment | Corticosteroids, Chemotherapy, Radiation therapy |
| Medication | N/A |
| Prognosis | Variable, depends on organ involvement |
| Frequency | Rare |
| Deaths | N/A |
Non-Langerhans cell histiocytosis is a group of rare diseases characterized by the accumulation of non-Langerhans cells, which are a type of white blood cell, in various organs and tissues. These diseases can affect both children and adults.
Classification[edit]
Non-Langerhans cell histiocytosis can be classified into several types, including Rosai-Dorfman disease, Juvenile xanthogranuloma, Erdheim-Chester disease, and Reticulohistiocytosis. Each of these diseases has unique clinical features and may affect different organs and tissues.
Symptoms[edit]
The symptoms of non-Langerhans cell histiocytosis vary depending on the specific type of disease and the organs and tissues affected. Common symptoms may include skin lesions, bone pain, and organ dysfunction.
Diagnosis[edit]
The diagnosis of non-Langerhans cell histiocytosis is typically made based on a combination of clinical findings, imaging studies, and histopathological examination of tissue samples. Immunohistochemical staining is often used to confirm the diagnosis.
Treatment[edit]
The treatment of non-Langerhans cell histiocytosis depends on the specific type of disease and the severity of symptoms. Treatment options may include surgery, radiation therapy, chemotherapy, and targeted therapies.
Prognosis[edit]
The prognosis of non-Langerhans cell histiocytosis varies widely depending on the specific type of disease and the organs and tissues affected. Some forms of the disease are self-limiting and resolve without treatment, while others may be chronic or life-threatening.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


